Impact of ibrutinib dose adjustment on TTNT in first-line CLL/SLL: a real-world analysis using target trial emulation
Autor: | Ghosh, Nilanjan, Wang, Ruibin, Qureshi, Zaina P., Ding, Zhijie, Lafeuille, Marie-Hélène, Emond, Bruno, Moore, Bronwyn, He, Jinghua, Bokun, Alex, Mavani, Heena, Rogers, Kerry A. |
---|---|
Zdroj: | In Blood Neoplasia September 2024 1(3) |
Databáze: | ScienceDirect |
Externí odkaz: |